Screener
Praxis Precision Medicines, Inc. PRAX Balance Sheet Statement
| Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | ||
|---|---|---|---|---|---|---|
| $474.76M+201% | $536.75M+223% | $357.75M+65.8% | $149.94M-11.3% | $157.83M+8.4% | ||
| $283.79M+97.3% | $250.53M+54.2% | $242M+36.6% | $117.63M-37.6% | $143.86M-30.4% | ||
| $771.9M+152% | $797.77M+139% | $610.91M+51.1% | $273.84M-23.9% | $306.58M-14.1% | ||
| $492K+90.7% | $170K-31.2% | $147K-36.1% | $174K-37.2% | $258K-30.1% | ||
| $773K— | —— | $0— | —— | —— | ||
| $1.39B+207% | $1.46B+205% | $937.91M+94.1% | $396.39M-4.8% | $452.83M+2.7% | ||
| $23.39M-18.9% | $31.16M+36.0% | $24.63M+96.6% | $30.82M+105% | $28.83M+252% | ||
| $49.06M+0.9% | $50.24M+27.1% | $59.77M+59.2% | $52.88M+60.9% | $48.61M+136% | ||
| $49.06M+0.9% | $50.24M+27.1% | $59.77M+58.7% | $52.88M+57.4% | $48.61M+121% | ||
| 150M0.0% | 150M0.0% | 150M+1,071,329% | 150M0.0% | 150M0.0% | ||
| -$1.32B-34.7% | -$1.23B-36.0% | -$1.14B-36.2% | -$1.05B-35.1% | -$977.16M-34.6% | ||
| $1.34B+232% | $1.41B+221% | $878.14M+97.1% | $343.51M-10.2% | $404.22M-3.5% | ||
| $1.39B+207% | $1.46B+205% | $937.91M+94.1% | $396.39M-4.8% | $452.83M+2.7% |
FAQ
- What are Praxis Precision Medicines, Inc.'s total assets?
- Praxis Precision Medicines, Inc. (PRAX) holds $1.4B in total assets, up 207.0% year over year.
- How much debt does Praxis Precision Medicines, Inc. have?
- Praxis Precision Medicines, Inc. carries $1.1M in total debt against $1.3B of shareholders' equity, a debt-to-equity ratio of 0.00.
- How much cash does Praxis Precision Medicines, Inc. have?
- Praxis Precision Medicines, Inc. holds $474.8M in cash and equivalents.
- Can Praxis Precision Medicines, Inc. cover its short-term obligations?
- Its current ratio is 15.73 — current assets exceed current liabilities.
- Where does Praxis Precision Medicines, Inc.'s balance sheet data come from?
- Every line is extracted from Praxis Precision Medicines, Inc.'s SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.